Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Leukemia

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 125 articles:
HTML format
Text format



Single Articles


    January 2019
  1. MICHELIS R, Tadmor T, Barhoum M, Shehadeh M, et al
    A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.
    PLoS One. 2019;14:e0209024.
    PubMed     Text format     Abstract available


  2. BALLO O, Tarazzit I, Stratmann J, Reinheimer C, et al
    Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy.
    PLoS One. 2019;14:e0210991.
    PubMed     Text format     Abstract available


  3. STEINER M, Schneider L, Yillah J, Gerlach K, et al
    FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation.
    PLoS One. 2019;14:e0210515.
    PubMed     Text format     Abstract available


  4. CASTILLO D, Galvez JM, Herrera LJ, Rojas F, et al
    Leukemia multiclass assessment and classification from Microarray and RNA-seq technologies integration at gene expression level.
    PLoS One. 2019;14:e0212127.
    PubMed     Text format     Abstract available


  5. MULU FENTIE A, Tadesse F, Engidawork E, Gebremedhin A, et al
    Prevalence and determinants of non-adherence to Imatinib in the first 3-months treatment among newly diagnosed Ethiopian's with chronic myeloid leukemia.
    PLoS One. 2019;14:e0213557.
    PubMed     Text format     Abstract available


  6. KITAMURA H, Tabe Y, Ai T, Tsuchiya K, et al
    A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib.
    PLoS One. 2019;14:e0207170.
    PubMed     Text format     Abstract available


  7. PANDITA A, Ramadas P, Poudel A, Saad N, et al
    Differential expression of miRNAs in acute myeloid leukemia quantified by Nextgen sequencing of whole blood samples.
    PLoS One. 2019;14:e0213078.
    PubMed     Text format     Abstract available


  8. SONG Y, Gyarmati P
    Bacterial translocation in acute lymphocytic leukemia.
    PLoS One. 2019;14:e0214526.
    PubMed     Text format     Abstract available


  9. SANDNER AS, Weggel R, Mehraein Y, Schneider S, et al
    Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.
    PLoS One. 2019;14:e0215453.
    PubMed     Text format     Abstract available


  10. LO TH, Abadir E, Gasiorowski RE, Kabani K, et al
    Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.
    PLoS One. 2019;14:e0216368.
    PubMed     Text format     Abstract available


  11. GUO J, Han Y, Li Y, Reddick WE, et al
    Reduced brain microstructural asymmetry in patients with childhood leukemia treated with chemotherapy compared with healthy controls.
    PLoS One. 2019;14:e0216554.
    PubMed     Text format     Abstract available


  12. JEPSEN LO, Friis LS, Hansen DG, Marcher CW, et al
    Living with outpatient management as spouse to intensively treated acute leukemia patients.
    PLoS One. 2019;14:e0216821.
    PubMed     Text format     Abstract available


  13. FOSTER KL, Kern KD, Chambers TM, Lupo PJ, et al
    Weight trends in a multiethnic cohort of pediatric acute lymphoblastic leukemia survivors: A longitudinal analysis.
    PLoS One. 2019;14:e0217932.
    PubMed     Text format     Abstract available


  14. PETRYKEY K, Lippe S, Robaey P, Sultan S, et al
    Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.
    PLoS One. 2019;14:e0217314.
    PubMed     Text format     Abstract available


  15. WOO YM, Kim S, Park JH, Lee NY, et al
    Evidence that 6q25.1 variant rs6931104 confers susceptibility to chronic myeloid leukemia through RMND1 regulation.
    PLoS One. 2019;14:e0218968.
    PubMed     Text format     Abstract available


  16. NARAYAN R, Olsson N, Wagar LE, Medeiros BC, et al
    Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin.
    PLoS One. 2019;14:e0219547.
    PubMed     Text format     Abstract available


  17. MEYER LK, Delgado-Martin C, Maude SL, Shannon KM, et al
    CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition.
    PLoS One. 2019;14:e0220026.
    PubMed     Text format     Abstract available


  18. TROJANI A, Pungolino E, Dal Molin A, Lodola M, et al
    Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment.
    PLoS One. 2019;14:e0218444.
    PubMed     Text format     Abstract available


  19. SONG DY, Kim JA, Jeong D, Yun J, et al
    Telomere length and its correlation with gene mutations in chronic lymphocytic leukemia in a Korean population.
    PLoS One. 2019;14:e0220177.
    PubMed     Text format     Abstract available


  20. YOSHINARI GH JR, Fassoni AC, Mello LF, Rego EM, et al
    Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia.
    PLoS One. 2019;14:e0221011.
    PubMed     Text format     Abstract available


    January 2018
  21. POHLEN M, Thoennissen NH, Braess J, Thudium J, et al
    Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.
    PLoS One. 2018;13:e0190802.
    PubMed     Text format     Abstract available


  22. ROUT ED, Burnett RC, Labadie JD, Yoshimoto JA, et al
    Preferential use of unmutated immunoglobulin heavy variable region genes in Boxer dogs with chronic lymphocytic leukemia.
    PLoS One. 2018;13:e0191205.
    PubMed     Text format     Abstract available


  23. KOLDEHOFF M, Lindemann M, Ross SR, Elmaagacli AH, et al
    Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line.
    PLoS One. 2018;13:e0191482.
    PubMed     Text format     Abstract available


  24. GETZ KD, Miller TP, Seif AE, Li Y, et al
    Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia.
    PLoS One. 2018;13:e0192529.
    PubMed     Text format     Abstract available


  25. OHATA Y, Tsuchiya M, Hirai H, Yamaguchi S, et al
    Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma.
    PLoS One. 2018;13:e0191865.
    PubMed     Text format     Abstract available


  26. KOKHAEI P, Hojjat-Farsangi M, Mozaffari F, Moshfegh A, et al
    Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells.
    PLoS One. 2018;13:e0192839.
    PubMed     Text format     Abstract available


  27. LANGE A, Jaskula E, Lange J, Dworacki G, et al
    The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.
    PLoS One. 2018;13:e0190525.
    PubMed     Text format     Abstract available


  28. GRUNDY M, Seedhouse C, Jones T, Elmi L, et al
    Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling.
    PLoS One. 2018;13:e0190682.
    PubMed     Text format     Abstract available


  29. KLONOFF-COHEN H, Navarro A, Klonoff EA
    Late effects awareness website for pediatric survivors of acute lymphocytic leukemia.
    PLoS One. 2018;13:e0193141.
    PubMed     Text format     Abstract available


  30. KULLING PM, Olson KC, Hamele CE, Toro MF, et al
    Dysregulation of the IFN-gamma-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
    PLoS One. 2018;13:e0193429.
    PubMed     Text format     Abstract available


  31. DZNELADZE I, Woolley JF, Rossell C, Han Y, et al
    SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.
    PLoS One. 2018;13:e0191510.
    PubMed     Text format     Abstract available


  32. COULIBALY A, Haas A, Steinmann S, Jakobs A, et al
    The natural anti-tumor compound Celastrol targets a Myb-C/EBPbeta-p300 transcriptional module implicated in myeloid gene expression.
    PLoS One. 2018;13:e0190934.
    PubMed     Text format     Abstract available


  33. GRZYWOCZ Z, Hoser G, Sabalinska S, Ladyzynski P, et al
    Response of human normal and leukemia cells to factors released by amnion fragments in vitro.
    PLoS One. 2018;13:e0195035.
    PubMed     Text format     Abstract available


  34. CHANG H, Gao Q, Ding W, Qing X, et al
    Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
    PLoS One. 2018;13:e0194245.
    PubMed     Text format     Abstract available


  35. PANAGOPOULOS I, Gorunova L, Jacobsen EM, Andersen K, et al
    RUNX1-PDCD6 fusion resulting from a novel t(5;21)(p15;q22) chromosome translocation in myelodysplastic syndrome secondary to chronic lymphocytic leukemia.
    PLoS One. 2018;13:e0196181.
    PubMed     Text format     Abstract available


  36. SPIESS B, Naumann N, Galuschek N, Rinaldetti S, et al
    The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
    PLoS One. 2018;13:e0196326.
    PubMed     Text format     Abstract available


  37. SCHRAW JM, Yiu TT, Lupo PJ, Tsavachidis S, et al
    Maternal folate genes and aberrant DNA hypermethylation in pediatric acute lymphoblastic leukemia.
    PLoS One. 2018;13:e0197408.
    PubMed     Text format     Abstract available


  38. KSIONDA O, Mues M, Wandler AM, Donker L, et al
    Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.
    PLoS One. 2018;13:e0193849.
    PubMed     Text format     Abstract available


  39. ALI SA, Malakar D, Kaushik JK, Mohanty AK, et al
    Recombinant purified buffalo leukemia inhibitory factor plays an inhibitory role in cell growth.
    PLoS One. 2018;13:e0198523.
    PubMed     Text format     Abstract available


  40. LIEN MY, Chou CH, Lin CC, Bai LY, et al
    Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.
    PLoS One. 2018;13:e0197851.
    PubMed     Text format     Abstract available


  41. BLUME JD, D'Agostino McGowan L, Dupont WD, Greevy RA Jr, et al
    Second-generation p-values: Improved rigor, reproducibility, & transparency in statistical analyses.
    PLoS One. 2018;13:e0188299.
    PubMed     Text format     Abstract available


  42. GARCIA-VIDAL C, Cardozo-Espinola C, Puerta-Alcalde P, Marco F, et al
    Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance.
    PLoS One. 2018;13:e0199531.
    PubMed     Text format     Abstract available


  43. ZHANG H, Song G, Song G, Li R, et al
    Identification of DNA methylation prognostic signature of acute myelocytic leukemia.
    PLoS One. 2018;13:e0199689.
    PubMed     Text format     Abstract available


  44. WU TH, Shi L, Adrian J, Shi M, et al
    NF90/ILF3 is a transcription factor that promotes proliferation over differentiation by hierarchical regulation in K562 erythroleukemia cells.
    PLoS One. 2018;13:e0193126.
    PubMed     Text format     Abstract available


  45. TRAN AN, Taylan F, Zachariadis V, Ivanov Ofverholm I, et al
    High-resolution detection of chromosomal rearrangements in leukemias through mate pair whole genome sequencing.
    PLoS One. 2018;13:e0193928.
    PubMed     Text format     Abstract available


  46. NORGAARD CH, Jakobsen LH, Gentles AJ, Dybkaer K, et al
    Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study.
    PLoS One. 2018;13:e0193249.
    PubMed     Text format     Abstract available


  47. OOSTEROM N, Griffioen PH, den Hoed MAH, Pieters R, et al
    Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
    PLoS One. 2018;13:e0199574.
    PubMed     Text format     Abstract available


  48. BENADIBA J, Ansari M, Krajinovic M, Vachon MF, et al
    Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children.
    PLoS One. 2018;13:e0193862.
    PubMed     Text format     Abstract available


  49. NOBRE AFS, Almeida DS, Ferreira LC, Ferreira DL, et al
    Low genetic diversity of the Human T-cell Lymphotropic Virus (HTLV-1) in an endemic area of the Brazilian Amazon basin.
    PLoS One. 2018;13:e0194184.
    PubMed     Text format     Abstract available


  50. CHACHAJ A, Wisniewski J, Rybka J, Butrym A, et al
    Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.
    PLoS One. 2018;13:e0197148.
    PubMed     Text format     Abstract available


  51. NAGEL S, Meyer C, Kaufmann M, Zaborski M, et al
    Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset.
    PLoS One. 2018;13:e0197194.
    PubMed     Text format     Abstract available


  52. CLARISSE D, Van Wesemael K, Tavernier J, Offner F, et al
    Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
    PLoS One. 2018;13:e0197000.
    PubMed     Text format     Abstract available


  53. MOORE TC, Messer RJ, Hasenkrug KJ
    Regulatory T cells suppress virus-specific antibody responses to Friend retrovirus infection.
    PLoS One. 2018;13:e0195402.
    PubMed     Text format     Abstract available


  54. GENTIL M, Hugues P, Desterke C, Telliam G, et al
    Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
    PLoS One. 2018;13:e0200923.
    PubMed     Text format     Abstract available


  55. GRUNDY M, Jones T, Elmi L, Hall M, et al
    Early changes in rpS6 phosphorylation and BH3 profiling predict response to chemotherapy in AML cells.
    PLoS One. 2018;13:e0196805.
    PubMed     Text format     Abstract available


  56. KREUGER AL, Middelburg RA, Beckers EAM, de Vooght KMK, et al
    The identification of cases of major hemorrhage during hospitalization in patients with acute leukemia using routinely recorded healthcare data.
    PLoS One. 2018;13:e0200655.
    PubMed     Text format     Abstract available


  57. BURNS W, Peloquin K, Rondeau E, Drouin S, et al
    Cancer-related effects on relationships, long-term psychological status and relationship satisfaction in couples whose child was treated for leukemia: A PETALE study.
    PLoS One. 2018;13:e0203435.
    PubMed     Text format     Abstract available


  58. TSUCHIYA K, Tabe Y, Ai T, Ohkawa T, et al
    Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes.
    PLoS One. 2018;13:e0202429.
    PubMed     Text format     Abstract available


  59. JAKEL F, Worm O, Lange S, Mertelsmann R, et al
    A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia.
    PLoS One. 2018;13:e0204393.
    PubMed     Text format     Abstract available


  60. IBANEZ M, Carbonell-Caballero J, Such E, Garcia-Alonso L, et al
    The modular network structure of the mutational landscape of Acute Myeloid Leukemia.
    PLoS One. 2018;13:e0202926.
    PubMed     Text format     Abstract available


  61. HATTORI H, Ishikawa Y, Kawashima N, Akashi A, et al
    Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia.
    PLoS One. 2018;13:e0204850.
    PubMed     Text format     Abstract available


  62. BRESIN A, Ragone G, Cristofoletti C, Arcelli D, et al
    T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
    PLoS One. 2018;13:e0204775.
    PubMed     Text format     Abstract available


  63. CARON M, St-Onge P, Drouin S, Richer C, et al
    Very long intergenic non-coding RNA transcripts and expression profiles are associated to specific childhood acute lymphoblastic leukemia subtypes.
    PLoS One. 2018;13:e0207250.
    PubMed     Text format     Abstract available


  64. KAGEYAMA Y, Miwa H, Arakawa R, Tawara I, et al
    Expression of CD25 fluctuates in the leukemia-initiating cell population of CD25-positive AML.
    PLoS One. 2018;13:e0209295.
    PubMed     Text format     Abstract available


  65. SCHUBERT M, Hackl H, Gassner FJ, Greil R, et al
    Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia.
    PLoS One. 2018;13:e0208753.
    PubMed     Text format     Abstract available


  66. KUZELOVA K, Brodska B, Schetelig J, Rollig C, et al
    Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.
    PLoS One. 2018;13:e0204290.
    PubMed     Text format     Abstract available


  67. NORGAARD CH, Sogaard NB, Biccler JL, Pilgaard L, et al
    Limited value of routine follow-up visits in chronic lymphocytic leukemia managed initially by watch and wait: A North Denmark population-based study.
    PLoS One. 2018;13:e0208180.
    PubMed     Text format     Abstract available


  68. KOBLISH H, Li YL, Shin N, Hall L, et al
    Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.
    PLoS One. 2018;13:e0199108.
    PubMed     Text format     Abstract available


  69. SCHEICH S, Koenig R, Wilke AC, Lindner S, et al
    Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival.
    PLoS One. 2018;13:e0201169.
    PubMed     Text format     Abstract available


  70. NG KP, Manjeri A, Lee LM, Chan ZE, et al
    The arginase inhibitor Nomega-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target.
    PLoS One. 2018;13:e0205254.
    PubMed     Text format     Abstract available


  71. PILLING LC, Atkins JL, Kuchel GA, Ferrucci L, et al
    Red cell distribution width and common disease onsets in 240,477 healthy volunteers followed for up to 9 years.
    PLoS One. 2018;13:e0203504.
    PubMed     Text format     Abstract available


  72. KOBLIHOVA J, Srutova K, Krutska M, Klamova H, et al
    AFLP-AFLP in silico-NGS approach reveals polymorphisms in repetitive elements in the malignant genome.
    PLoS One. 2018;13:e0206620.
    PubMed     Text format     Abstract available


  73. VILLANUEVA PJ, Martinez A, Baca ST, DeJesus RE, et al
    Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis.
    PLoS One. 2018;13:e0206467.
    PubMed     Text format     Abstract available


    January 2017
  74. YANG L, Sun H, Cao Y, Xuan B, et al
    Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
    PLoS One. 2017;12:e0175005.
    PubMed     Text format     Abstract available


  75. LAJOIE M, Drouin S, Caron M, St-Onge P, et al
    Specific expression of novel long non-coding RNAs in high-hyperdiploid childhood acute lymphoblastic leukemia.
    PLoS One. 2017;12:e0174124.
    PubMed     Text format     Abstract available


  76. JABO B, Morgan JW, Martinez ME, Ghamsary M, et al
    Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients.
    PLoS One. 2017;12:e0174760.
    PubMed     Text format     Abstract available


  77. KALLEMEIJN MJ, de Ridder D, Schilperoord-Vermeulen J, van der Klift MY, et al
    Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRgammadelta+ T cell large granular lymphocyte leukemia.
    PLoS One. 2017;12:e0175670.
    PubMed     Text format     Abstract available


  78. TSUNAKA M, Shinki H, Koyama T
    Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia.
    PLoS One. 2017;12:e0175765.
    PubMed     Text format     Abstract available


  79. YE X, Torabi M, Lix LM, Mahmud SM, et al
    Time and spatial trends in lymphoid leukemia and lymphoma incidence and survival among children and adolescents in Manitoba, Canada: 1984-2013.
    PLoS One. 2017;12:e0175701.
    PubMed     Text format     Abstract available


  80. NISHIMORI A, Konnai S, Okagawa T, Maekawa N, et al
    In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection.
    PLoS One. 2017;12:e0174916.
    PubMed     Text format     Abstract available


  81. GUTIERREZ-CAMINO A, Martin-Guerrero I, Garcia de Andoin N, Sastre A, et al
    Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population.
    PLoS One. 2017;12:e0177421.
    PubMed     Text format     Abstract available


  82. MONDEJAR R, Perez C, Onaindia A, Martinez N, et al
    Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.
    PLoS One. 2017;12:e0177524.
    PubMed     Text format     Abstract available


  83. KARATHEDATH S, Rajamani BM, Musheer Aalam SM, Abraham A, et al
    Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2.
    PLoS One. 2017;12:e0177227.
    PubMed     Text format     Abstract available


  84. ALEXANDER PM, Caudell DL, Kucera GL, Pladna KM, et al
    The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia.
    PLoS One. 2017;12:e0179798.
    PubMed     Text format     Abstract available


  85. BUEHRING GC, Shen H, Schwartz DA, Lawson JS, et al
    Bovine leukemia virus linked to breast cancer in Australian women and identified before breast cancer development.
    PLoS One. 2017;12:e0179367.
    PubMed     Text format     Abstract available


  86. DOS SANTOS PC, Panero J, Stanganelli C, Palau Nagore V, et al
    Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia.
    PLoS One. 2017;12:e0179883.
    PubMed     Text format     Abstract available


  87. WINKLER MT, Bushey RT, Gottlin EB, Campa MJ, et al
    Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody.
    PLoS One. 2017;12:e0179841.
    PubMed     Text format     Abstract available


  88. GU R, Wei H, Wang Y, Lin D, et al
    The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia.
    PLoS One. 2017;12:e0180624.
    PubMed     Text format     Abstract available


  89. WOYWOD C, Gruber FX, Engh RA, Fla T, et al
    Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy.
    PLoS One. 2017;12:e0179700.
    PubMed     Text format     Abstract available


  90. ALONSO-DOMINGUEZ JM, Casado LF, Anguita E, Gomez-Casares MT, et al
    PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase.
    PLoS One. 2017;12:e0181366.
    PubMed     Text format     Abstract available


  91. BANDYOPADHYAY S, Li J, Traer E, Tyner JW, et al
    Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia.
    PLoS One. 2017;12:e0179558.
    PubMed     Text format     Abstract available


  92. MCKENZIE LM, Allshouse WB, Byers TE, Bedrick EJ, et al
    Childhood hematologic cancer and residential proximity to oil and gas development.
    PLoS One. 2017;12:e0170423.
    PubMed     Text format     Abstract available


  93. ARCHER NP, Perez-Andreu V, Stoltze U, Scheurer ME, et al
    Family-based exome-wide association study of childhood acute lymphoblastic leukemia among Hispanics confirms role of ARID5B in susceptibility.
    PLoS One. 2017;12:e0180488.
    PubMed     Text format     Abstract available


  94. MARCEL V, Catez F, Berger CM, Perrial E, et al
    Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients.
    PLoS One. 2017;12:e0170160.
    PubMed     Text format     Abstract available


  95. MITSUHASHI Y, Furusawa Y, Aradate T, Zhao QL, et al
    3-O-trans-p-coumaroyl-alphitolic acid, a triterpenoid from Zizyphus jujuba, leads to apoptotic cell death in human leukemia cells through reactive oxygen species production and activation of the unfolded protein response.
    PLoS One. 2017;12:e0183712.
    PubMed     Text format     Abstract available


  96. SETHI MK, Thol F, Stadler M, Heuser M, et al
    VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation.
    PLoS One. 2017;12:e0168096.
    PubMed     Text format     Abstract available


  97. ALSOUS M, Abu Farha R, Alefishat E, Al Omar S, et al
    Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia.
    PLoS One. 2017;12:e0183119.
    PubMed     Text format     Abstract available


  98. BRODSKA B, Kracmarova M, Holoubek A, Kuzelova K, et al
    Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM.
    PLoS One. 2017;12:e0175175.
    PubMed     Text format     Abstract available


  99. BANJAR H, Ranasinghe D, Brown F, Adelson D, et al
    Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia.
    PLoS One. 2017;12:e0168947.
    PubMed     Text format     Abstract available


  100. LAVROV AV, Ustaeva OA, Adilgereeva EP, Smirnikhina SA, et al
    Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia.
    PLoS One. 2017;12:e0182901.
    PubMed     Text format     Abstract available


  101. WANG Y, Yin Y, Lan X, Ye F, et al
    Molecular characterization, expression of chicken TBK1 gene and its effect on IRF3 signaling pathway.
    PLoS One. 2017;12:e0177608.
    PubMed     Text format     Abstract available


  102. FUCHS H, Rossmann N, Schmid MB, Hoenig M, et al
    Permissive hypercapnia for severe acute respiratory distress syndrome in immunocompromised children: A single center experience.
    PLoS One. 2017;12:e0179974.
    PubMed     Text format     Abstract available


  103. BELVISO S, Iuliano R, Amato R, Perrotti N, et al
    The human asparaginase enzyme (ASPG) inhibits growth in leukemic cells.
    PLoS One. 2017;12:e0178174.
    PubMed     Text format     Abstract available


  104. ISAEVSKA E, Manasievska M, Alessi D, Mosso ML, et al
    Cancer incidence rates and trends among children and adolescents in Piedmont, 1967-2011.
    PLoS One. 2017;12:e0181805.
    PubMed     Text format     Abstract available


  105. FATEHCHAND K, Santhanam R, Shen B, Erickson EL, et al
    Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells.
    PLoS One. 2017;12:e0181729.
    PubMed     Text format     Abstract available


  106. PRABHU KS, Siveen KS, Kuttikrishnan S, Iskandarani A, et al
    Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells.
    PLoS One. 2017;12:e0180895.
    PubMed     Text format     Abstract available


  107. LEE CH, Lin JC, Ho CL, Sun M, et al
    Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
    PLoS One. 2017;12:e0180050.
    PubMed     Text format     Abstract available


  108. GORDIIENKO I, Shlapatska L, Kholodniuk V, Sklyarenko L, et al
    The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
    PLoS One. 2017;12:e0185940.
    PubMed     Text format     Abstract available


  109. LATHAM S, Hughes E, Budgen B, Mechinaud F, et al
    Sources of error in measurement of minimal residual disease in childhood acute lymphoblastic leukemia.
    PLoS One. 2017;12:e0185556.
    PubMed     Text format     Abstract available


  110. CHOI SH, Severson E, Pear WS, Liu XS, et al
    The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.
    PLoS One. 2017;12:e0185762.
    PubMed     Text format     Abstract available


  111. WONG SM, Liu FH, Lee YL, Huang HM, et al
    Correction: MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.
    PLoS One. 2017;12:e0186531.
    PubMed     Text format     Abstract available


  112. LEE YL, Chen CW, Liu FH, Huang YW, et al
    Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation.
    PLoS One. 2017;12:e0186528.
    PubMed     Text format     Abstract available


  113. BUTI M, Manzano ML, Morillas RM, Garcia-Retortillo M, et al
    Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
    PLoS One. 2017;12:e0184550.
    PubMed     Text format     Abstract available


  114. WEIR MC, Hellwig S, Tan L, Liu Y, et al
    Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
    PLoS One. 2017;12:e0181178.
    PubMed     Text format     Abstract available


  115. LI S, Jin X, Wu H, Wang Y, et al
    HA117 endows HL60 cells with a stem-like signature by inhibiting the degradation of DNMT1 via its ability to down-regulate expression of the GGL domain of RGS6.
    PLoS One. 2017;12:e0180142.
    PubMed     Text format     Abstract available


  116. TAVERNA L, Tremolada M, Bonichini S, Tosetto B, et al
    Motor skill delays in pre-school children with leukemia one year after treatment: Hematopoietic stem cell transplantation therapy as an important risk factor.
    PLoS One. 2017;12:e0186787.
    PubMed     Text format     Abstract available


  117. ZHANG P, Zhao X, Zhang W, He A, et al
    Leukemia-associated gene MLAA-34 reduces arsenic trioxide-induced apoptosis in HeLa cells via activation of the Wnt/beta-catenin signaling pathway.
    PLoS One. 2017;12:e0186868.
    PubMed     Text format     Abstract available


  118. ASKMYR M, von Palffy S, Hansen N, Landberg N, et al
    Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.
    PLoS One. 2017;12:e0186035.
    PubMed     Text format     Abstract available


  119. MEHANNA P, Gagne V, Lajoie M, Spinella JF, et al
    Characterization of the microDNA through the response to chemotherapeutics in lymphoblastoid cell lines.
    PLoS One. 2017;12:e0184365.
    PubMed     Text format     Abstract available


  120. CHABER R, Gurgul A, Wrobel G, Haus O, et al
    Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL).
    PLoS One. 2017;12:e0187422.
    PubMed     Text format     Abstract available


  121. MIN H, Niu M, Zhang W, Yan J, et al
    Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein.
    PLoS One. 2017;12:e0187971.
    PubMed     Text format     Abstract available


  122. DUCHARTRE Y, Bachl S, Kim HN, Gang EJ, et al
    Effects of CD49d-targeted antisense-oligonucleotide on alpha4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies.
    PLoS One. 2017;12:e0187684.
    PubMed     Text format     Abstract available


  123. HAGE-SLEIMAN R, Bahmad H, Kobeissy H, Dakdouk Z, et al
    Genomic alterations during p53-dependent apoptosis induced by gamma-irradiation of Molt-4 leukemia cells.
    PLoS One. 2017;12:e0190221.
    PubMed     Text format     Abstract available


  124. BASNETT J, Xie V, Cisterne A, Bradstock K, et al
    Regulation of the bone marrow microenvironment by G-CSF: Effects of G-CSF on acute lymphoblastic leukaemia.
    PLoS One. 2017;12:e0188042.
    PubMed     Text format     Abstract available


  125. CARRETTA M, Brouwers-Vos AZ, Bosman M, Horton SJ, et al
    BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.
    PLoS One. 2017;12:e0189102.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: